drugset / Trial / NCT07597629
A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, multicenter Phase II clinical study conducted in subjects with advanced breast cancer.
Timeline
- Start
- 2026-05-25
- Primary completion
- 2027-11-30
- Completion
- 2029-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYS6023 | Other / unclassified | — | Intravenous |
| Background | KN026 | Monoclonal antibody | — | Intravenous |